Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.21 -0.11 (-0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Other Accumulated Expenses (2022 - 2023)

Updated

Dianthus Therapeutics (DNTH) recorded Other Accumulated Expenses of $279,000 in Q2 2023, up 24.6% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Other Accumulated Expenses (2022 - 2023) Analysis & Trends

At the end of FY2022, Dianthus Therapeutics reported Other Accumulated Expenses of $364,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Dianthus Therapeutics 3.78 Bn 3.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 279,000.00
Mar 31, 2023 224,000.00
Dec 31, 2022 364,000.00
API Access

Dianthus Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=DNTH&period=max&api_key=YOUR_API_KEY